In a study that evaluated the effect of nutraceuticals, including resveratrol, on the inhibition of cervical cancer through the reactivation of PAX1, it was reported that resveratrol was capable of reactivating PAX1 expression in Caski cells [72]. Here, PAX1 is linked to cervical carcinoma.